BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12419790)

  • 1. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
    Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
    J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
    Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
    BMC Cancer; 2012 Jun; 12():257. PubMed ID: 22708928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
    Grabinski JL; Smith LS; Chisholm GB; Drengler R; Rodriguez GI; Lang AS; Kalter SP; Garner AM; Fichtel LM; Hollsten J; Pollock BH; Kuhn JG
    Breast Cancer Res Treat; 2006 Jan; 95(1):13-6. PubMed ID: 16317586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
    Seth P; Lunetta KL; Bell DW; Gray H; Nasser SM; Rhei E; Kaelin CM; Iglehart DJ; Marks JR; Garber JE; Haber DA; Polyak K
    Cancer Res; 2000 Dec; 60(24):6859-63. PubMed ID: 11156380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
    Gjerde J; Hauglid M; Breilid H; Lundgren S; Varhaug JE; Kisanga ER; Mellgren G; Steen VM; Lien EA
    Ann Oncol; 2008 Jan; 19(1):56-61. PubMed ID: 17947222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women.
    Han DF; Zhou X; Hu MB; Wang CH; Xie W; Tan XD; Zheng F; Liu F
    Toxicol Lett; 2004 Apr; 150(2):167-77. PubMed ID: 15093672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.
    Wegman P; Vainikka L; Stål O; Nordenskjöld B; Skoog L; Rutqvist LE; Wingren S
    Breast Cancer Res; 2005; 7(3):R284-90. PubMed ID: 15987423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.
    Nowell SA; Ahn J; Rae JM; Scheys JO; Trovato A; Sweeney C; MacLeod SL; Kadlubar FF; Ambrosone CB
    Breast Cancer Res Treat; 2005 Jun; 91(3):249-58. PubMed ID: 15952058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
    Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
    Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
    Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.
    Moyer AM; Suman VJ; Weinshilboum RM; Avula R; Black JL; Safgren SL; Kuffel MJ; Ames MM; Ingle JN; Goetz MP
    Pharmacogenomics; 2011 Nov; 12(11):1535-43. PubMed ID: 21961651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
    Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
    Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study.
    Zheng L; Wang Y; Schabath MB; Grossman HB; Wu X
    Cancer Lett; 2003 Dec; 202(1):61-9. PubMed ID: 14643027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study.
    Lilla C; Risch A; Kropp S; Chang-Claude J
    Breast Cancer Res; 2005; 7(2):R229-37. PubMed ID: 15743503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy.
    Sanchez-Spitman AB; Dezentjé VO; Swen JJ; Moes DJAR; Gelderblom H; Guchelaar HJ
    Breast Cancer Res Treat; 2018 Nov; 172(2):401-411. PubMed ID: 30120701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
    Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Wolf G; Wascher TC; Paulweber B; Weitzer W; Samonigg H
    Breast Cancer Res Treat; 2004 Sep; 87(1):19-22. PubMed ID: 15377847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.
    Sillanpää P; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K; Hirvonen A
    Pharmacogenet Genomics; 2005 Oct; 15(10):749-52. PubMed ID: 16141802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis.
    Wang Y; Spitz MR; Tsou AM; Zhang K; Makan N; Wu X
    Lung Cancer; 2002 Feb; 35(2):137-42. PubMed ID: 11804685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SULT1A1 Copy Number Variation on Estrogen Concentration and Tamoxifen-Associated Adverse Drug Reactions in Premenopausal Thai Breast Cancer Patients: A Preliminary Study.
    Charoenchokthavee W; Ayudhya DP; Sriuranpong V; Areepium N
    Asian Pac J Cancer Prev; 2016; 17(4):1851-5. PubMed ID: 27221864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.